Skip to main navigation Skip to search Skip to main content

A high scale SARS-CoV-2 profiling by its whole-genome sequencing using Oxford Nanopore Technology in Kazakhstan

  • Nazarbayev University

Research output: Contribution to journalArticlepeer-review

Abstract

Severe acute respiratory syndrome (SARS-CoV-2) is responsible for the worldwide pandemic, COVID-19. The original viral whole-genome was sequenced by a high-throughput sequencing approach from the samples obtained from Wuhan, China. Real-time gene sequencing is the main parameter to manage viral outbreaks because it expands our understanding of virus proliferation, spread, and evolution. Whole-genome sequencing is critical for SARS-CoV-2 variant surveillance, the development of new vaccines and boosters, and the representation of epidemiological situations in the country. A significant increase in the number of COVID-19 cases confirmed in August 2021 in Kazakhstan facilitated a need to establish an effective and proficient system for further study of SARS-CoV-2 genetic variants and the development of future Kazakhstan's genomic surveillance program. The SARS-CoV-2 whole-genome was sequenced according to SARS-CoV-2 ARTIC protocol (EXP-MRT001) by Oxford Nanopore Technologies at the National Laboratory Astana, Kazakhstan to track viral variants circulating in the country. The 500 samples kindly provided by the Republican Diagnostic Center (UMC-NU) and private laboratory KDL "Olymp" were collected from individuals in Nur-Sultan city diagnosed with COVID-19 from August 2021 to May 2022 using real-time reverse transcription-quantitative polymerase chain reaction (RT-qPCR). All samples had a cycle threshold (Ct) value below 20 with an average Ct value of 17.03. The overall average value of sequencing depth coverage for samples is 244X. 341 whole-genome sequences that passed quality control were deposited in the Global initiative on sharing all influenza data (GISAID). The BA.1.1 ( n = 189), BA.1 ( n = 15), BA.2 ( n = 3), BA.1.15 ( n = 1), BA.1.17.2 ( n = 1) omicron lineages, AY.122 ( n = 119), B.1.617.2 ( n = 8), AY.111 ( n = 2), AY.126 ( n = 1), AY.4 ( n = 1) delta lineages, one sample B.1.1.7 ( n = 1) belongs to alpha lineage, and one sample B.1.637 ( n = 1) belongs to small sublineage were detected in this study. This is the first study of SARS-CoV-2 whole-genome sequencing by the ONT approach in Kazakhstan, which can be expanded for the investigation of other emerging viral or bacterial infections on the country level.

Original languageEnglish
Article number906318
Pages (from-to)906318
JournalFrontiers in Genetics
Volume13
DOIs
Publication statusPublished - Sept 2 2022

Funding

This work was funded by the Nazarbayev University’s internal grant for research (#280720FD 1909) and the grant project “Whole genome sequencing of SARS-CoV-2 in high scale for monitoring the coronavirus variants during COVID-19 pandemic in Kazakhstan”.

FundersFunder number
Nazarbayev University280720FD 1909

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 1 - No Poverty
      SDG 1 No Poverty
    2. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being
    3. SDG 6 - Clean Water and Sanitation
      SDG 6 Clean Water and Sanitation
    4. SDG 12 - Responsible Consumption and Production
      SDG 12 Responsible Consumption and Production

    Keywords

    • COVID-19
    • Kazakhstan
    • Oxford Nanopore
    • SARS-CoV-2 genome sequencing
    • third-generation sequencing

    ASJC Scopus subject areas

    • Molecular Medicine
    • Genetics
    • Genetics(clinical)

    Fingerprint

    Dive into the research topics of 'A high scale SARS-CoV-2 profiling by its whole-genome sequencing using Oxford Nanopore Technology in Kazakhstan'. Together they form a unique fingerprint.

    Cite this